Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).
Trailfinders founder, Mike Gooley CBE, has supported our work for more than 20 years. His latest gift will support the Francis Crick Institute’s PhD programme.
Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress
Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease.
A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.
Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.
53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings
The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer.
Cancer Research UK and the US National Cancer Institute, are uniting to define a new era in cancer research and discovery.